Guyer William's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Nov 5, 2024
- Accession no.
- 0000950170-24-121742
- Filed
- Nov 5, 2024
- Trade date
- Nov 1-4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $489.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Guyer WilliamCIK 0001879013 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Common Stock | MOption exerciseAcquired | +6,606 | $21.65 | +$143,019.9 | 12,402 | Direct | |
| Nov 1, 2024 | Common Stock | SSaleDisposed | −6,606 | $48.97 | −$323,495.82 | 5,796 | Direct | |
| Nov 4, 2024 | Common Stock | MOption exerciseAcquired | +3,394 | $21.65 | +$73,480.1 | 9,190 | Direct | |
| Nov 4, 2024 | Common Stock | SSaleDisposed | −3,394 | $48.97 | −$166,204.18 | 5,796 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Common Stock | MOption exerciseDisposed | −6,606 | $0.00 | $0 | 453,394 | Direct | |
| Nov 4, 2024 | Common Stock | MOption exerciseDisposed | −3,394 | $0.00 | $0 | 450,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The power of attorney under which this form was signed is on file with the Commission.